Reaction

Broncholithiasis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 31 reports · 3 co-occurring drugs

As of the last recalculation, Broncholithiasis appears in 31 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 3,733.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ciclesonide223,733.03,739.1
Tiotropium Bromide Inhalation Spray9759.3760.0
Salicylic Acid15368.0368.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.